Pfeffingen, Switzerland

Urs A Boelsterli

This inventor holds 1 USPTO granted patent. Top assignee: Biospherics Incorporated. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Urs A Boelsterli. Retrieved from https://idiyas.com/inventor/urs-a-boelsterli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Urs A. Boelsterli: Innovator in Organ Preservation**

Introduction

Urs A. Boelsterli is an astute inventor based in Pfeffingen, Switzerland. With a pivotal contribution to the field of organ preservation, he has developed a novel approach aimed at reducing reperfusion injury during surgical procedures. Through his innovative mindset and dedication to advancing medical technology, he stands out as a significant figure in his field.

Latest Patents

Boelsterli holds one notable patent: "Tagatose as a cytoprotective supplement for the removal and/or storage of organs to reduce reperfusion injury." This patent focuses on the addition of tagatose to an organ storage and preservation solution to mitigate reperfusion injury during surgery and following the removal of the organ from the donor. This innovation has the potential to enhance the success rates of organ transplants, ultimately benefiting patients in need of life-saving procedures.

Career Highlights

Currently, Urs A. Boelsterli is associated with Biospherics Incorporated. His work at this company emphasizes the intersection of innovative research and practical applications in organ preservation. His dedication to improving medical practices through scientific research is evident in his patented work.

Collaborations

While specific collaborations are not detailed, the nature of his work in organ preservation likely involves partnerships with medical institutions, universities, and potentially government agencies focused on healthcare advancements. Such collaborations are crucial in translating innovative ideas into real-world medical solutions.

Conclusion

Urs A. Boelsterli's contributions to organ preservation technology through his patent demonstrate a strong commitment to enhancing surgical outcomes and patient care. His innovative approach using tagatose highlights the importance of research and development in the medical field. As he continues his work, the impact of his inventions may lead to significant advancements in organ transplantation and preservation practices globally.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…